- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/08 - Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigoAntiemetics
Patent holdings for IPC class A61P 1/08
Total number of patents in this class: 506
10-year publication summary
|
28
|
24
|
24
|
33
|
41
|
55
|
46
|
41
|
30
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2708 |
19 |
| Acacia Pharma Limited | 41 |
16 |
| Helsinn Healthcare SA | 229 |
11 |
| Vanda Pharmaceuticals, Inc. | 352 |
10 |
| Altria Client Services LLC | 2172 |
8 |
| Duchesnay Inc. | 62 |
7 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1348 |
7 |
| Eisai R&D Management Co., Ltd. | 1234 |
6 |
| Cindome Pharma, Inc. | 13 |
6 |
| Starton Therapeutics, Inc. | 24 |
6 |
| Pfizer Inc. | 3370 |
5 |
| Kissei Pharmaceutical Co., Ltd. | 184 |
5 |
| Shionogi & Co., Ltd. | 867 |
5 |
| Hoffmann-La Roche Inc. | 3387 |
4 |
| Evoke Pharma, Inc. | 25 |
4 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
4 |
| Lankenau Institute for Medical Research | 95 |
4 |
| LTS Lohmann Therapie-Systeme AG | 691 |
4 |
| Raqualia Pharma Inc. | 122 |
4 |
| Vetagro International SRL | 56 |
4 |
| Other owners | 367 |